
Director, Global Regulatory Liaison - Immunology
Merck
Summary
The Director (Principal Scientist), Global Regulatory Liaison reports to the Executive Director, General Medicine and is responsible for development and implementation of worldwide regulatory strategies for their assigned projects within the Immunology Therapeutic Area. The individual provides regulatory oversight for assigned products, to optimize product labeling and obtain shortest time to approval by global regulatory agencies.
Job description
Key Functions
- Develops worldwide product regulatory strategies to optimize labeling and obtain shortest time to approval by regulatory agencies for assigned indications
- Assesses regulatory/competitive landscape to establish global regulatory strategies that facilitate speed-to-market and the delivery of targeted product labeling
- Provides expert advice as the Global Regulatory Lead to Product Development Teams and regulatory single point-of-contact for products within and external to GRACS
- Provides leadership to the Global Regulatory Team which coordinates cross-functional regulatory support for development programs and marketed products
- Coordinates the preparation, submission and follow-up contact with regulatory agencies and/or subsidiaries for all applications and submissions
- Reviews and provides final approval of local registration study protocols when needed to obtain marketing authorization in secondary markets
- Interact independently with regulatory agencies (FDA, EMA, etc.), including leading meetings, teleconferences, and written communications
- Coordinate regional regulatory strategy and submissions through collaboration with Regulatory Affairs Europe (RAE) and local affiliate teams
- Reviews Worldwide Marketing Applications, Clinical Study Reports, protocols, Investigator Brochures
- Prepares IND/CTAs for global studies related to investigational drugs/biologics
- Participates in regulatory due diligence activities for licensing candidate reviews
Requirements
- B.S. or M.S. with a minimum of 7 years of relevant drug development experience with majority in regulatory, or M.D. or PhD/PharmD with a minimum of 5 years relevant drug development experience with three years in regulatory
- Strong strategic thinking, problem-solving, and continuous learning mindset
- Effective communicator—both written and verbal—with the ability to influence, lead, and negotiate across levels and functions
- Experience leading or supporting direct interactions with major Health Authorities (e.g., FDA, EMA)
- Demonstrated expertise in leading regulatory filings across global regions
- Drug Development
- Global Regulatory
- Pharmaceutical Industry
- Pharmaceutical Research
- Product Registrations
- Regulatory Affairs Management
- Regulatory Communications
- Regulatory Processes
- Regulatory Strategies
- Regulatory Submissions
- Strategic Leadership
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.